FILE – Iga Swiatek of Poland looks on during her match against Irina-Camelia Begu of Romania during a women’s singles tennis competition, at the 2024 Summer Olympics, Saturday, July 27, 2024, in Paris, France. (AP Photo/Manu Fernandez, File)
The International Tennis Integrity Agency (ITIA) said on Thursday that world number two Iga Swiatek has accepted a one-month suspension after testing positive for banned substance trimetazidine (TMZ).
The Polish player had tested positive in an out-of-competition sample back in August but the agency noted that it was caused by contamination of her medication melatonin which she has been taking for sleep issues and jet lag.